A majority of U.S. senators and representatives receive campaign funding from pharmaceutical companies — an important part of the expanding national conversation about navigating conflicts of interest ...
The lawmakers said that Congress did not receive the 30-day notice or the reason for the IG’s removals which took place at over a dozen agencies.